[Apropos of 2 cases of lymphangiomyomatosis treated with LH-RH agonists].
Radermecker
M A
MA
CHU, Service de Chirurgie cardio-vasculaire, Université de Liège.
Corhay
J L
JL
Broux
R
R
Gustin
M
M
Noël
F
F
Borlée
G
G
Bury
T
T
Saint-Remy
P
P
Gaspard
U
U
Limet
R
R
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002064:Buserelin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D008203:Lymphangiomyoma / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D008525:Medroxyprogesterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone; D002064:Buserelin
A propos de 2 cas de lymphangiomyomatose traités par agoniste de la LH-RH.